FDAnews
www.fdanews.com/articles/132326-enforcement-efforts-prove-costly-to-device-and-drug-industries

Enforcement Efforts Prove Costly to Device and Drug Industries

December 2, 2010
The scope of the Justice Department’s stepped-up enforcement campaign against off-label marketing and other violations of the False Claims Act is coming into focus, with the agency saying it has recovered nearly $5 billion in taxpayer funds since January 2009. In addition to the recovered funds, Justice has collected more than $3 billion in fines and secured 25 criminal convictions in that time period, Assistant Attorney General Tony West said. The device and drug industries accounted for about $1.6 billion of the taxpayer funds, as well as significant fines
Devices & Diagnostics Letter